Hims & Hers Health Inc. (NYSE:HIMS) posted its second-quarter results after Monday’s closing bell, missing analysts’ EPS estimate, but beating on revenue. Here’s a look at the details inside the report.
- HIMS stock is moving. Watch the price action here.
Hims & Hers Q2 Details
Hims & Hers Health reported quarterly losses of 37 cents per share which missed the analyst consensus estimate for losses of three cents, according to Benzinga Pro data.
Quarterly revenue came in at $753.21 million which beat the Street estimate of $699.889 million and was up from $544.83 million in the same period last year.
The company highlighted subscriber growth to nearly 2.9 million, up 19% year-over-year in the second quarter.
Looking Ahead
Hims & Hers raised its fiscal 2026 revenue outlook to between $3.1 billion and $3.3 billion, versus the $2.93 billion analyst estimate.
HIMS Stock Price Activity: According to data from Benzinga Pro, Hims & Hers shares were down 5.61% to $29.99 in Monday’s extended trading.
Photo: Shutterstock
Login to comment